Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932

Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932

Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932

Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932

Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932

Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932

Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932

Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932

Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932

Stubbs, Harrison and Cannon, John and Knightbridge, Emily and Durrington, Charlotte and Roddis, Chloe and Gin-Sing, Wendy and Massey, Fiona and Knight, Daniel S. and Virsinskaite, Ruta and Lordan, James L. and Sear, Eleanoe and Apple-Pinguel, Joy and Morris, Eleanor and Johnson, Martin K. and Wort, Stephen J. (2024) Sendaway capillary NT-proBNP in pulmonary hypertension. BMJ Open Respiratory Research, 11 (1): e002124. ISSN 2052-4439

Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932

Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932

Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932

Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932

Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932

Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932

Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932

Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932

Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932

Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932

Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932

Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932

Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932

Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932

Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932

Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932

Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932

Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932

Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932

Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932

Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932

Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932

Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932

Taylor, Rod and Burrell, Emma and O’Hare, Claire and Thomson, Elizabeth and Placzek, Anna and Bollen, Jessica and Cleland, John G.F. and Cowie, Ansley and Dalal, Hasnain and Deaton, Christi and Doherty, Patrick and Dudman, Katie and Fraser, Heather and Frost, Julia and Greaves, Colin J. and Hartshorne-Evans, Nick and Hillsdon, Melvyn and Ibbotson, Tracy and Jarallah, Mohammad and Jolly, Kate and McConnachie, Alex and McIntosh, Emma and Smith, Valerie and Squire, Iain and Taylor, Louise and van Beurden, Sam and Lang, Chim C. and REACH-HFpEF investigators (2025) Clinical effectiveness and cost-effectiveness of the rehabilitation enablement in chronic heart failure facilitated self-care rehabilitation intervention for people with heart failure with preserved ejection fraction and their caregivers: rationale and protocol for a multicentre randomised controlled trial – REACH-HFpEF trial. BMJ Open, 15 (5): e094254. ISSN 2044-6055

Muir, Keith and Ford, Gary A. and Ford, Ian and Wardlaw, Joanna M. and McConnachie, Alex and Greenlaw, Nicola and Mair, Grant and Sprigg, Nikola and Price, Christopher I. and MacLeod, Mary Joan and Dima, Sofia and Venter, Marius and Zhang, Liqun and O’Brien, Eoin and Sanyal, Ranjan and Reid, John and Sztriha, Laszlo K. and Haider, Syed and Whiteley, William N. and Kennedy, James and Perry, Richard and Marigold, Richard and Raghunathan, Senthil and Sims, Don and Bhandari, Mohit and Wiggam, Ivan and Rashed, Khalid and Douglass, Chris (2024) Tenecteplase versus alteplase for acute stroke within 4·5 h of onset (ATTEST-2): a randomised, parallel group, open-label trial. Lancet Neurology, 23 (11). pp. 1087-1096. ISSN 1474-4422

Dagnan, Dave and Thompson, Paul and Hastings, Richard P. and Hatton, Chris and Melville, Craig and Cooper, Sally-Ann and McMeekin, Nicola and Fulton, Lauren and Jones, Rob S.P. and McConnachie, Alex and Jahoda, Andrew (2024) The influence of therapy quality on outcomes from behavioural activation and guided self-help treatments for depression in adults with intellectual disabilities. British Journal of Clinical Psychology, 64 (2). pp. 139-147. ISSN 0144-6657

Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932

Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932

Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932

Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932

Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1): e12337. ISSN 2045-8932